Bacitracin Zinc and Polymyxin B Sulfate Ointment
»Bacitracin Zinc and Polymyxin B Sulfate Ointment contains the equivalent of not less than 90.0percent and not more than 130.0percent of the labeled amounts of bacitracin and polymyxin B.It may contain a suitable local anesthetic.
Packaging and storage
Preserve in well-closed,light-resistant containers.
Thin-layer chromatographic identification test á201BNPñ:
meets the requirements.
Minimum fill á755ñ:
meets the requirements.
Water,Method Iá921ñ:
not more than 0.5%,20mLof a mixture of toluene and methanol (7:3)being used in place of methanol in the titration vessel.
Assay for polymyxin B
Proceed as directed for polymyxin Bunder AntibioticsMicrobial Assays á81ñ,using an accurately weighed portion of Ointment shaken with about 50mLof ether in a separator,and extracted with four 20-mLportions of Buffer No.6.Combine the aqueous extracts,and dilute with Buffer No.6to an appropriate volume to obtain a stock solution.Dilute this stock solution quantitatively and stepwise with Buffer No.6to obtain a Test Dilutionhaving a concentration assumed to be equal to the median dose level of the Standard.
Auxiliary Information
Staff Liaison:William W.Wright,Ph.D.,Scientific Fellow
Expert Committee:(PA7)Pharmaceutical Analysis 7
USP28NF23Page 216
Pharmacopeial Forum:Volume No.28(4)Page 1071
Phone Number:1-301-816-8335
|